Global Anti-Suicide Drugs Market Size, by Product (Anti-Depressant Drug, Anti-Anxiety Drug), by Route of Administration (Oral, Parenteral) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1139772
  • |
  • Date : July-2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Anti-Suicide Drugs Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increasing prevalence depression and anxiety are driving the market growth. However stringent government policies due to drug abuse might hamper the market growth.

The global anti-suicide drugs market is primarily segmented based on product, route of administration and regions.

On the basis of product, the market is split into:
* Anti-Depressant Drug
* Anti-Anxiety Drug
* Anti-Psychotic Drug
* NMDA Antagonist
* Antibiotic Analogues

On the basis of route of administration, the market is split into:
* Oral
* Parenteral

Moreover, the market is classified based on region and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* AstraZeneca plc
* Allergan plc
* Eli Lilly and Company
* H. Lundbeck A/S
* GlaxoSmithKline plc
* Johnson & Johnson
* Merck & Co.
* Pfizer Inc.
* NeuroRx, Inc.
* Cipla Limited

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, product, route of administration and market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions product, route of administration and options with qualitative and quantitative information and facts

Target Audience:
* Anti-Suicide Drugs Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Anti-Suicide Drugs Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Anti-Suicide Drugs Market - Porter\'s Five Forces Analysis
4.4. Global Anti-Suicide Drugs Market - PESTEL Analysis

5. Global Anti-Suicide Drugs Market, by Application
5.1. Global Anti-Suicide Drugs Market, Size and Forecast, 2015-2026
5.2. Global Anti-Suicide Drugs Market by Anti-Depressant Drug, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Anti-Suicide Drugs Market by Anti-Anxiety Drug, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Anti-Suicide Drugs Market by Anti-Psychotic Drug, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Anti-Suicide Drugs Market by NMDA Antagonist, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global Anti-Suicide Drugs Market by Antibiotic Analogues, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Anti-Suicide Drugs Market, by Route of Administration
6.1. Global Anti-Suicide Drugs Market, Size and Forecast, 2015-2026
6.2. Global Anti-Suicide Drugs Market by Oral, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Anti-Suicide Drugs Market by Parenteral, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026

7. Global Anti-Suicide Drugs Market by Region
7.1. Anti-Suicide Drugs Market Regional Analysis, 2015-2026
7.2. Global Anti-Suicide Drugs Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Anti-Suicide Drugs Market, 2015-2026
7.3.1. North America Anti-Suicide Drugs Market Size and Forecast, 2015-2026
7.3.2. North America Anti-Suicide Drugs Market by Country, 2015-2026
7.3.2.1. U.S. Anti-Suicide Drugs Market, 2015-2026
7.3.2.2. Canada Anti-Suicide Drugs Market, 2015-2026
7.4. Europe Anti-Suicide Drugs Market, 2015-2026
7.4.1. Europe Anti-Suicide Drugs Market Size and Forecast, 2015-2026
7.4.2. Europe Anti-Suicide Drugs Market by Country, 2015-2026
7.4.2.1. Germany Anti-Suicide Drugs Market, 2015-2026
7.4.2.2. France Anti-Suicide Drugs Market, 2015-2026
7.4.2.3. Italy Anti-Suicide Drugs Market, 2015-2026
7.4.2.4. UK Anti-Suicide Drugs Market, 2015-2026
7.4.2.5. Spain Anti-Suicide Drugs Market, 2015-2026
7.4.2.6. Rest of Europe Anti-Suicide Drugs Market, 2015-2026
7.5. Asia Pacific Anti-Suicide Drugs Market, 2015-2026
7.5.1. Asia Pacific Anti-Suicide Drugs Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Anti-Suicide Drugs Market by Country, 2015-2026
7.5.2.1. Japan Anti-Suicide Drugs Market, 2015-2026
7.5.2.2. China Anti-Suicide Drugs Market, 2015-2026
7.5.2.3. India Anti-Suicide Drugs Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Anti-Suicide Drugs Market, 2015-2026
7.6. South America Anti-Suicide Drugs Market, 2015-2026
7.6.1. South America Anti-Suicide Drugs Market Size and Forecast, 2015-2026
7.6.2. South America Anti-Suicide Drugs Market by Country, 2015-2026
7.6.2.1. Mexico Anti-Suicide Drugs Market, 2015-2026
7.6.2.2. Brazil Anti-Suicide Drugs Market, 2015-2026
7.6.2.3. Rest of South America Anti-Suicide Drugs Market, 2015-2026
7.7. Middle East & Africa Anti-Suicide Drugs Market, 2015-2026
7.7.1. Middle East & Africa Anti-Suicide Drugs Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Anti-Suicide Drugs Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Anti-Suicide Drugs Market, 2015-2026
7.7.2.2. South Africa Anti-Suicide Drugs Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Anti-Suicide Drugs Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. AstraZeneca plc
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Allergan plc
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Eli Lilly and Company
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. H. Lundbeck A/S
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. GlaxoSmithKline plc
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Johnson & Johnson
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Merck & Co.
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Pfizer Inc.
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. NeuroRx, Inc.
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Cipla Limited
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type